The Long Run with Luke Timmerman podcast

Ep188: Art Krieg on Innate Immune System Activators for Cancer

28/10/2025

The Long Run with Luke Timmerman

0:00

1:09:05

Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.

Otros episodios de "The Long Run with Luke Timmerman"

Ep188: Art Krieg on Innate Immune System Activators for Cancer
28/10/2025
1:09:05
Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.
Ep187: Eric Fischer on Creating a New Class of Medicines
14/10/2025
1:05:48
Eric Fischer, a professor at Dana-Farber Cancer Institute, on creating a new class medicines -- targeted protein degraders.
No te pierdas ningún episodio de “The Long Run with Luke Timmerman”. Síguelo en la aplicación gratuita de GetPodcast.
Ep186: Bruce Levine & Mags McCarthy on a Song About Science and Hope
29/9/2025
1:02:33
Bruce Levine, a CAR-T cell therapy researcher at the University of Pennsylvania, and Mags McCarthy, a country music star, discuss their new song about science and hope for cancer patients.
Ep185: Dr. Lachelle Weeks on Predicting Leukemia Risk At Scale
17/9/2025
1:05:47
Dr. Lachelle Weeks is a physician-scientist at Dana-Farber Cancer Institute working on a project to predict leukemia risk based on widely available blood samples.
Ep184: Jen Adair on Affordable, Accessible Gene & Cell Therapies
28/8/2025
1:50:23
Jen Adair, professor and associate director of the Horae Gene Therapy Center at the University of Massachusetts Chan Medical School, on creating more affordable and accessible cell and gene therapies.
Ep183: Sabah Oney on CAR-T Cells Against Solid Tumors
6/8/2025
56:23
Sabah Oney, CEO of Philadelphia and San Francisco-based Dispatch Biotherapeutics, on engineering CAR-T cells that can kill solid tumors.
Ep182: Andy Rachleff & Yung Lie on Creative Ways to Back Science
23/7/2025
1:01:18
Andy Rachleff and Yung Lie, board chair and CEO of Damon Runyon Cancer Research Foundation, on creative ways to support science amid budget cuts.
Ep181: Claire Mazumdar on a Two-Pronged Attack Against Cancer
1/7/2025
57:18
Claire Mazumdar, CEO of Boston-based Bicara Therapeutics, on developing a bifunctional antibody for head and neck cancer.
Ep180: John Rinn on Discovering Drugs Based on Long Non-Coding RNA
11/6/2025
1:10:45
John Rinn, professor at the University of Colorado and co-founder of Lincswitch Therapeutics, on exploring long non-coding RNA.
Ep179: Ethan Weiss & Josh Lehrer on a New Idea for Cardiovascular Disease & Diabetes
28/5/2025
1:03:25
Marea Therapeutics CEO Josh Lehrer and CSO Ethan Weiss on a new angle of attack against cardiovascular disease and diabetes.

Más episodios

Descubre los mejores podcast en la aplicación gratuita de GetPodcast.

Suscríbete a tus podcast favoritos, escucha episodios cuando estés sin conexión y déjate sorprender por las recomendaciones personalizadas.

Ep188: Art Krieg on Innate Immune System Activators for Cancer

The Long Run with Luke Timmerman

Otros episodios de "The Long Run with Luke Timmerman"

Ep188: Art Krieg on Innate Immune System Activators for Cancer

Ep187: Eric Fischer on Creating a New Class of Medicines

Ep186: Bruce Levine & Mags McCarthy on a Song About Science and Hope

Ep185: Dr. Lachelle Weeks on Predicting Leukemia Risk At Scale

Ep184: Jen Adair on Affordable, Accessible Gene & Cell Therapies

Ep183: Sabah Oney on CAR-T Cells Against Solid Tumors

Ep182: Andy Rachleff & Yung Lie on Creative Ways to Back Science

Ep181: Claire Mazumdar on a Two-Pronged Attack Against Cancer

Ep180: John Rinn on Discovering Drugs Based on Long Non-Coding RNA

Ep179: Ethan Weiss & Josh Lehrer on a New Idea for Cardiovascular Disease & Diabetes